Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06965127

Implant for Walking After Incomplete SCI

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in people with incomplete spinal cord injury. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes implanting the device and setting the individual up for system use, creating controllers for walking, and evaluating the effect of the device over a couple years.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Louis Stokes Cleveland Veterans Affairs Medical Center

Cleveland, Ohio, 44106, United States

Location status: Recruiting

Location contact

Lisa Lombardo, MPT

CONTACT

[email protected]

216-791-3800 ext. 64909

Maura Malenchek, PTA

CONTACT

[email protected]

216-791-3800 ext. 64989

Nathan Makowski, PhD

PRINCIPAL_INVESTIGATOR

About this study

The purpose of this study is to evaluate the effects of neural stimulation for improving walking after incomplete spinal cord injury. Participants will conduct pre-surgical gait training and then undergo surgery to implant a stimulator and electrodes to sense from and activate muscles used during walking. The device delivers electrical pulses to the nerves causing the muscles to contract to perform functional movements. The system coordinates assistance based on implanted sensors. After receiving the implanted device, participants undergo training to use the device to assist walking. Evaluations are completed prior to surgery as well after training and at later follow up sessions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18-75
  • Non-ventilator dependent paralysis resulting from injuries such as: cervical/thoracic spinal cord injuries affecting the trunk and/or lower limbs
  • Impairment classification of AIS B, C, or D (preservation of sensation and/or some motor function) with weakness in trunk and/or lower extremity muscles
  • Unable to walk faster than 0.8m/s during a 10m walk test
  • Gait deviation such as reduced peak hip, knee, and/or ankle range of motion during stance or swing phases due to motor impairment
  • Time post injury greater than six months
  • Innervated and excitable lower extremity and trunk musculature
  • Adequate social support and stability
  • Willingness to comply with follow-up procedures
  • Appropriate body habitus (height and weight within acceptable limits as determined by study physician)
  • Neurologically stable as determined by a physician

Exclusion criteria

  • Significant fracture risk or history of spontaneous fractures
  • History of heterotopic ossification at the hip, knee, or ankle
  • Non-English speaking
  • Insufficient upper extremity function to use an assistive device (e.g. walker or cane)
  • Females who are pregnant
  • Current pressure injury that would be exacerbated by study activities
  • Uncontrolled spasticity that would interfere with study activities
  • Significant range of motion limitations that would compromise study activities
  • History of vestibular dysfunction, balance problems, or spontaneous falls
  • Disorder or condition that require MRI monitoring
  • Acute and/or untreated orthopedic issues that would prevent weight bearing or exercising implanted muscles such as a dislocation or fracture
  • Acute and/or chronic medical problems left untreated or not controlled that would increase risk by using stimulation such as cardiac abnormalities, immunological/pulmonary/renal/circulatory compromise
  • Uncontrolled diabetes or hypertension
  • Presence of a demand pacemaker, cardiac defibrillator, or neuroprosthesis system with components in the legs
  • Any other medical or psychological condition that would be a contraindication

Implant eligibility criteria

  • In addition to all of the above, the participant must be able to fully support their body weight in standing with an assistive device prior to implantation.

Treatment and study plan

NNP-LE

Device

Networked NeuroProsthesis - Lower Extremity Configuration (NNP-LE) measuring physiologic command signals and delivering neural stimulation to intramuscular and nerve cuff electrodes for trunk and leg muscle assistance.

Primary outcomes

  1. Difference in maximum walking distance

    Time frame: Immediately after the participant is fully trained to use their implanted system

    The maximum walking distance is a measure of how far the participant can walk within a single bout over an unconstrained period of time. The measure is used to assess whether endurance and walking capacity improve. The difference between walking with and without the system turned on determines if the system improves walking capacity. Users serve as their own concurrent controls.

Secondary outcomes

  1. Difference in spinal cord injury - functional ambulation inventory (SCI-FAI)

    Time frame: Immediately after the participant is fully trained to use their implanted system

    The SCI-FAI is an observational gait assessment that assesses three areas of walking: gait parameters, assistive device use, and walking mobility. The difference between walking with and without the system turned on determines if the system improves walking ability. Users serve as their own concurrent controls with and without device assistance.

  2. Difference in Home and community mobility

    Time frame: Baseline and Immediately after the participant is fully trained to use their implanted system

    A body worn step counter measures the number of steps taken daily over the course of about a month prior to implantation and then after implantation and system use. The difference between walking before and after having the system identifies if people walk more once they have the system. Users serve as their own longitudinal controls.

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa Lombardo, MPT

CONTACT

[email protected]

216-791-3800 ext. 64909

Maura Malenchek, PTA

CONTACT

[email protected]

216-791-3800 ext. 64989

Sponsors and collaborators

Lead sponsor

Louis Stokes VA Medical Center

Fed

Collaborators

  • Congressionally Directed Medical Research Programs
  • MetroHealth Medical Center

Registry information

Official study title

Enhancing Walking and Independence After Incomplete SCI With a Fully Implanted Neuroprosthesis

Important dates

Study start
2025
Primary completion
2028
Study completion
2031
First posted
May 11, 2025
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.